BJD Talks - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

BJD Talks — Science
BJD Talks

The official podcast of the British Journal of Dermatology

Copyright: © All rights reserved

Latest Episodes:

Episode 55 - Keratinocyte cancer trends in England 2013–2022 Oct 23, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Trends in keratinocyte cancers in England, 2013–22: basal cell carcinoma incidence, cutaneous squamous cell carcinoma incidence and nonmelanoma skin cancer mortality’ by Mistry et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag315

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 54 - Subcutaneous efgartigimod in pemphigus: phase III ADDRESS trial Oct 23, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial’ by Joly et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag199

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 53 - Scaffold delivery of basement membrane motifs for wound healing Oct 07, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Engineered Caf1 constructs encoding laminin-332 motifs: a novel approach for enhanced cutaneous wound healing’ by Nie et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag235

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 52 - Durability of icotrokinra response through week 52 Oct 05, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials ’ by Stein Gold et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag264

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 51 - Skin cancer mortality in Australian and New Zealand kidney transplant recipients Oct 02, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Skin cancer mortality in Australian and New Zealand kidney transplant recipients: a population-based cohort study using linked health data, 1990–2019 ’ by Forcey et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag232

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 50 - Reducing infant bathing: a randomized controlled feasibility trial Sep 28, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Randomized controlled feasibility trial of an intervention to reduce infant bathing’ by Perkin et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag248

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 49 - Quality of life in patients with BCNS Aug 21, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Health-related quality of life in patients with basal cell naevus syndrome and high-frequency basal cell carcinoma: a questionnaire study’ by Massella Patsea et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag212

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 48 - Deucravacitinib in patients with alopecia areata in a phase II trial Aug 04, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial’ by King et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag109

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 47 - Serious infection risk with systemic treatments for psoriasis Jul 30, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)’ by Bright et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag174

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Episode 46 - Narrowband vs broadband UVB phototherapy for moderate-to-severe atopic dermatitis Jul 23, 2026

Show notes

In this episode of BJD Talks, Sam and Meera discuss the article ‘Narrowband versus broadband ultraviolet B phototherapy for adults with moderate-to-severe atopic dermatitis: a randomized controlled trial’ by Drucker et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag161

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Related Podcasts